Annual Follow-Up After Hemithyroidectomy
For patients after hemithyroidectomy, annual follow-up should include physical examination, TSH measurement, and neck ultrasonography, with the specific protocol varying based on whether the surgery was for benign disease or thyroid cancer.
For Benign Nodular Disease
Based on evidence-based recommendations, patients who undergo hemithyroidectomy for benign thyroid disease should receive 1:
- Annual physical examination
- Annual neck ultrasonography to detect recurrent nodular disease
- Annual serum TSH measurement to monitor for hypothyroidism
Timing and Duration of Monitoring
The risk of hypothyroidism is highest in the first year post-surgery, with most cases developing within 6-12 months 2. However, late-onset hypothyroidism can occur:
- First 3 months: 55.9% of hypothyroidism cases occur in this window 3
- First 12 months: 78% of cases develop within the first year 4
- Beyond 1 year: 22% of cases can develop after 12 months, necessitating continued surveillance 4
At minimum, follow-up should continue for at least 1 year to avoid missing patients who develop delayed hypothyroidism 5. Given that hypothyroidism can develop in up to 34% of patients by 3 years 6, and the 5-year risk reaches 27.5% in pediatric populations 4, annual monitoring should continue long-term.
For Thyroid Cancer (Differentiated Thyroid Cancer)
The follow-up protocol differs significantly based on cancer risk stratification 7:
Very Low-Risk Cancer (≤1 cm, unifocal, no adverse features)
- Cervical ultrasound at 6-12 months postoperatively
- Then at 5-10 years
- Near-zero recurrence risk allows extended surveillance intervals 7
Low-Risk Cancer
- Cervical ultrasound at 6-12 months, 3 years, and 5 years
- Then every 5 years thereafter
- Progressive spacing reflects the indolent nature of recurrence 7
Intermediate-Risk Cancer
- Annual ultrasound monitoring is recommended if completion thyroidectomy is not performed
- Recurrence risk can reach 25% in this group 7
Critical Distinction for Cancer Follow-Up
Thyroglobulin and thyroglobulin antibody levels are NOT recommended for monitoring after hemithyroidectomy 7. The remaining thyroid lobe produces thyroglobulin, making these markers unreliable. Cervical ultrasound is the primary surveillance modality.
Risk Factors for Hypothyroidism
Identify high-risk patients who require more vigilant TSH monitoring 2, 4, 3:
- Preoperative TSH ≥2.0-2.42 mIU/L (strongest predictor)
- Presence of TPO antibodies (7-fold increased risk)
- Hashimoto thyroiditis on pathology (59% hypothyroidism rate)
- Multinodular goiter (50% hypothyroidism rate)
- Family history of thyroid disease
- Larger specimen size (≥36.2 mm)
Patients with preoperative TSH <2 mIU/L have a low risk (12.8% at 5 years), while those with TSH ≥2 mIU/L have high risk (58.8% at 5 years) 4.
Common Pitfalls to Avoid
Discontinuing surveillance too early: One-third of patients develop hypothyroidism by 3 years 6, and cases can emerge after the first year 5, 4
Over-relying on thyroglobulin in cancer patients: This is unreliable after hemithyroidectomy due to the functioning remnant lobe 7
Missing transient hypothyroidism: 16% of patients experience transient hypothyroidism that may spontaneously resolve within 1 year 4. Avoid premature lifelong levothyroxine commitment when TSH elevations may be temporary.
Inadequate cancer surveillance: For intermediate-risk cancers, annual ultrasound is essential if completion thyroidectomy wasn't performed, as recurrence risk is substantial 7
Practical Algorithm
Year 1: Physical exam + TSH + neck ultrasound (every 3-6 months if high-risk features)
Years 2-5: Annual physical exam + TSH + neck ultrasound
Beyond 5 years:
- Benign disease: Continue annual TSH and ultrasound
- Very low-risk cancer: Ultrasound at 5-10 years only
- Low-risk cancer: Ultrasound every 5 years
- Intermediate-risk cancer: Annual ultrasound indefinitely